documents: FDA-2024-N-5717-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2024-N-5717-0001 FDA FDA-2024-N-5717 Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments— Supplemental New Drug Application 218276 S–004 for FABHALTA (iptacopan) Oral Capsules in the Treatment of Adults With C3G Notice Request for Comments 2024-12-30T05:00:00Z 2024 12 2024-12-30T05:00:00Z 2025-02-22T04:59:59Z 2025-02-22T02:00:45Z 2024-31309 0 0 09000064868952b7

Links from other tables